Bionano Genomics (BNGO) Other Non-Current Assets (2020 - 2026)

Bionano Genomics has reported Other Non-Current Assets for 7 years, with the latest figure at $2.7 million in Q1 2026.

• Quarterly Other Non-Current Assets changed N/A year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (changed N/A YoY) and the FY2025 annual result came in at $2.7 million, up 573.5% from the prior year.
• Other Non-Current Assets retreated to $2.7 million in Q1 2026 per BNGO's latest filing, from $2.7 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $11.4 million in Q2 2024 and troughed at $400000.0 in Q4 2022.
• A 5-year average of $2.4 million and a median of $400000.0 in 2022 frame the typical range for Other Non-Current Assets.
• The widest YoY moves for Other Non-Current Assets: up 2752.0% in 2024, down 94.62% in 2024.
• Over 5 years, Other Non-Current Assets stood at $400000.0 in 2022, then soared by 1757.75% to $7.4 million in 2023, then tumbled by 94.62% to $400000.0 in 2024, then soared by 573.5% to $2.7 million in 2025, then slipped by 0.59% to $2.7 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.7 million, $2.7 million, and $2.1 million for Q1 2026, Q4 2025, and Q2 2025 respectively.